Business Description
Telo Genomics Corp
NAICS : 621510
SIC : 8681
ISIN : CA88555C1077
Total Employee Number:
6Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | -0.79 | |||||
Debt-to-Equity | -1.36 | |||||
Debt-to-EBITDA | -0.58 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 4.5 | |||||
3-Year Book Growth Rate | -51.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.99 | |||||
9-Day RSI | 39.28 | |||||
14-Day RSI | 42.62 | |||||
3-1 Month Momentum % | 11.36 | |||||
6-1 Month Momentum % | -19.52 | |||||
12-1 Month Momentum % | -41.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.49 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -13272.73 | |||||
ROA % | -260.83 | |||||
ROIC % | -644.83 | |||||
3-Year ROIIC % | 2192.59 | |||||
ROC (Joel Greenblatt) % | -2473.52 | |||||
ROCE % | -4578.43 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -1.87 | |||||
EV-to-EBITDA | -1.91 | |||||
EV-to-FCF | -2.86 | |||||
Earnings Yield (Greenblatt) % | -53.48 | |||||
FCF Yield % | -37.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TDSGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telo Genomics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.028 | ||
| Beta | -0.5585 | ||
| 3-Year Sharpe Ratio | -0.59 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 52.13 | ||
| 14-Day RSI | 42.62 | ||
| 14-Day ATR ($) | 0.003468 | ||
| 20-Day SMA ($) | 0.037217 | ||
| 12-1 Month Momentum % | -41.61 | ||
| 52-Week Range ($) | 0.0196 - 0.09 | ||
| Shares Outstanding (Mil) | 100.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telo Genomics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telo Genomics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2019-11-22 | 0.12 (+13.17%) |
Show
Entries
Telo Genomics Corp Frequently Asked Questions
What is Telo Genomics Corp(TDSGF)'s stock price today?
The current price of TDSGF is $0.03. The 52 week high of TDSGF is $0.09 and 52 week low is $0.02.
When is next earnings date of Telo Genomics Corp(TDSGF)?
The next earnings date of Telo Genomics Corp(TDSGF) is .
Does Telo Genomics Corp(TDSGF) pay dividends? If so, how much?
Telo Genomics Corp(TDSGF) does not pay dividend.
Guru Commentaries on OTCPK:TDSGF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Telo Genomics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers